Didi Ubels

Ms. Didi Ubels

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MGMagdalena Gładysz
Magdalena Gładysz
DUDidi Ubels
Didi Ubels
MKMarcus Koch
Marcus Koch
AAArmin Amirsadeghi
Armin Amirsadeghi
FAFrederique Alleblas
Frederique Alleblas
Małgorzata K. Włodarczyk-BiegunMałgorzata K. Włodarczyk-Biegun
Małgorzata K. Włodarczyk-Biegun
Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here, poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV) and a blend of PHBV and poly(3‐hydroxybutyrate‐co‐4‐hydroxybutyrate) (PHBV+P34HB) are successfully melt electrowritten into scaffolds with various architectures. PHBV+P34HB exhibits greater thermal stability, making it a superior printing material compared to PHBV in MEW. The PHBV+P34HB scaffolds subjected to enzymatic degradation show tunable degradation times, governed by enzyme dilution, incubation time, and scaffold surface area. PHBV+P34HB scaffolds seeded with human dermal fibroblasts (HDFs), demonstrate enhanced cell adherence, proliferation, and spreading. The HDFs, when exposed to the enzyme solutions and enzymatic degradation residues, show good viability and proliferation rates. Additionally, HDFs grown on enzymatically pre‐incubated scaffolds do not show any difference in behavior compared those grown on control scaffolds. It is concluded that PHAs, as biobased materials with enzymatically tunable degradability rates, are an important addition to the already limited set of materials available for MEW technology.

11 July 2025 in Gels
Verified
Journal Article
Open access
PDF file
VGVasilena Getova
Vasilena Getova
ACAlex Pascual Cid
Alex Pascual Cid
RDRene Dijkstra
Rene Dijkstra
MGMagdalena Gładysz
Magdalena Gładysz
DUDidi Ubels
Didi Ubels
MHMartin Harmsen
Martin Harmsen
Multi-layer cell constructs produced in vitro are an innovative treatment option to support the growing demand for therapy in regenerative medicine. Our research introduces a novel construct integrating organ-derived decellularised extracellular matrix (dECM) hydrogels and 3D-printed biodegradable polymer meshes composed of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P34HB) to support and maintain multiple layers of different cell types. We achieved that by integrating the mechanical stability of PHBV+P34HB, commonly used in the food storage industry, with a dECM hydrogel, which replicates organ stiffness and supports cellular survival and function. The construct was customised by adjusting the fibre arrangement and pore sizes, making it a suitable candidate for a personalised design. We showed that the polymer is degradable after precoating it with PHB depolymerase (PhaZ), with complete degradation achieved in 3–5 days and delayed by adding the hydrogel to 10 days, enabling tuneable degradation for regenerative medicine applications. Finally, as a proof of concept, we composed a three-layered tissue in vitro; each layer represented a different tissue type: epidermal, vascular, and subcutaneous layers. Possible future applications include wound healing and diabetic ulcer paths, personalised drug delivery systems, and personalised tissue implants.